Current and future biomarkers in gastric cancer

被引：45
|
作者：
Abbas, Muhammad [1 ,2 ,3 ]
Faggian, Alessia [4 ]
Sintali, Dahiru Nasiru [5 ]
Khan, Ghulam Jilany [6 ,7 ,8 ]
Naeem, Shagufta [9 ]
Shi, Meiqi [2 ,3 ]
Chen Dingding [1 ]
机构：
[1] China Pharmaceut Univ, Sch Basic Med & Clin Pharm, Dept Clin Pharm, Nanjing 211198, Jiangsu, Peoples R China
[2] Nanjing Med Univ, Affiliated Canc Hosp, Dept Oncol, Jiangsu Canc Hosp, 42 Baiziting, Nanjing 210009, Jiangsu, Peoples R China
[3] Jiangsu Inst Canc Res, 42 Baiziting, Nanjing 210009, Jiangsu, Peoples R China
[4] Azienda ULSS 3 Serenissima, SS Giovanni & Paolo Reg Hosp, Reg Ctr Biomarkers, Dept Clin Pathol & Transfus Med, Campo SS Giovanni & Paolo 6777, I-30122 Venice, VE, Italy
[5] China Pharmaceut Univ, Sch Pharm, Dept Pharm, Nanjing 211198, Jiangsu, Peoples R China
[6] China Pharmaceut Univ, Jiangsu Key Lab Drug Screening, Nanjing 210009, Jiangsu, Peoples R China
[7] Univ Cent Punjab, Fac Pharm, Dept Pharmacol & Therapeut, Lahore, Pakistan
[8] Southeast Univ, State Key Lab Bioelect, Sch Biol Sci & Med Engn, Nanjing 210096, Jiangsu, Peoples R China
[9] Ayub Med Coll, Dept Pathol, Abbottabad 22040, Pakistan
来源：
BIOMEDICINE & PHARMACOTHERAPY | 2018年 / 103卷
关键词：
Gastric cancer; Predictive biomarkers; Treatment; Signaling cascades; Response to treatments; Clinical significance; Emerging markers; GROWTH-FACTOR RECEPTOR; MULTICENTER PHASE-II; C-ERBB-2 PROTEIN EXPRESSION; E-CADHERIN; GENE AMPLIFICATION; MET EXPRESSION; LUNG-CANCER; FACTOR VEGF; C-MET; PROGNOSTIC-SIGNIFICANCE;
D O I：
10.1016/j.biopha.2018.04.178
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Gastric cancer is the fourth most common worldwide cause of cancer-related death. Early gastric cancer has no associated symptoms, for this reason, patients come to the attention of the clinicians only in advanced stages. This paper aims to give a global view on the biomarkers for gastric cancer and the therapy in use. We discuss VEGF family, HER family, E-cadherin, PD-L1, and PD-L2, FGFR, mTOR. Finally, we considered emerging biomarkers as MET, microsatellite instability, and microRNA variations. Furthermore, we have analyzed in depth the chemotherapeutic and adjuvant therapies used in the clinic nowadays, comparing the overall and progression-free survival between them. Identifying and validating diagnostic, prognostic, predictive, and pharmacodynamic biomarkers will be mandatory to the huge impact on patients' outcomes and for improving the efficiency of the drug development process.
引用
收藏
页码：1688 / 1700
页数：13
相关论文
共 50 条
  • [21] Epigenetic biomarkers in prostate cancer: Current and future uses
    Chiam, Karen
    Ricciardelli, Carmela
    Bianco-Miotto, Tina
    CANCER LETTERS, 2014, 342 (02) : 248 - 256
  • [22] Current and potential biomarkers in gastric cancer: a critical review of the literature
    de Mello, Ramon Andrade
    Amaral, Giovanna Araujo
    Neves, Nathalia Moises
    Lippo, Estela Gudin
    Parini, Fernanda
    Xu, Song
    Tolia, Maria
    Charalampakis, Nikolaos
    Tadokoro, Hakaru
    Castelo-Branco, Pedro
    Zhu, Jinhui
    FUTURE ONCOLOGY, 2021, 17 (25) : 3383 - 3396
  • [23] Current issues and future perspectives of gastric cancer screening
    Chisato Hamashima
    World Journal of Gastroenterology, 2014, (38) : 13767 - 13774
  • [24] Current and future strategies for radiation therapy in gastric cancer
    Mesci, Aruz
    Wong, Rebecca K. S.
    JOURNAL OF SURGICAL ONCOLOGY, 2022, 125 (07) : 1161 - 1175
  • [25] Adjuvant therapy for gastric cancer:Current and future directions
    Marcus Foo
    Trevor Leong
    World Journal of Gastroenterology, 2014, (38) : 13718 - 13727
  • [26] Current status and future perspectives in gastric cancer management
    Roukos, DH
    CANCER TREATMENT REVIEWS, 2000, 26 (04) : 243 - 255
  • [27] Current issues and future perspectives of gastric cancer screening
    Hamashima, Chisato
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (38) : 13767 - 13774
  • [28] Adjuvant therapy for gastric cancer: Current and future directions
    Foo, Marcus
    Leong, Trevor
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (38) : 13718 - 13727
  • [29] Current treatments and future perspectives in colorectal and gastric cancer
    Wilke, HJ
    Van Cutsem, E
    ANNALS OF ONCOLOGY, 2003, 14 : 49 - 55
  • [30] Imaging in Gastric Cancer: Current Practice and Future Perspectives
    Giandola, Teresa
    Maino, Cesare
    Marrapodi, Giuseppe
    Ratti, Michele
    Ragusi, Maria
    Bigiogera, Vittorio
    Talei Franzesi, Cammillo
    Corso, Rocco
    Ippolito, Davide
    DIAGNOSTICS, 2023, 13 (07)
12345